Back to mobile site

Exact Sciences (EXAS) Tops Q2 EPS by 5c

July 30, 2020 4:49 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.58), $0.05 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $268.9 million versus the consensus estimate of $228.42 million.


For earnings history and earnings-related data on Exact Sciences (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings